Carregant...

A trial of sublingual buprenorphine in cancer pain

1 Buprenorphine is a new antagonist analgesic which was offered sublingually to 141 patients with moderate cancer pain as an alternative to their current analgesic. These patients were not on regular strong morphine-like analgesics. 2 Forty-seven patients used the drug on demand in unit doses rangin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Robbie, D. S.
Format: Artigo
Idioma:Inglês
Publicat: 1979
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1429302/
https://ncbi.nlm.nih.gov/pubmed/380617
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!